Cargando…

Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis

BACKGROUND: Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is characterised by upper lobe-dominant fibrosis involving the pleura and subpleural lung parenchyma, with advanced cases often complicated by progressive weight loss. Therefore, we hypothesised that nutritional status is associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Yuzo, Fukada, Atsuki, Mori, Kazutaka, Kono, Masato, Hasegawa, Hirotsugu, Hashimoto, Dai, Yokomura, Koshi, Imokawa, Shiro, Inoue, Yusuke, Yasui, Hideki, Hozumi, Hironao, Karayama, Masato, Furuhashi, Kazuki, Enomoto, Noriyuki, Fujisawa, Tomoyuki, Inui, Naoki, Nakamura, Hidenori, Suda, Takafumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204813/ https://www.ncbi.nlm.nih.gov/pubmed/37228291 http://dx.doi.org/10.1183/23120541.00749-2022

Ejemplares similares

Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes
por: Nakamura, Yutaro, et al.
Publicado: (2021)

Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis
por: Suzuki, Yuzo, et al.
Publicado: (2018)

Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias
por: Fujisawa, Tomoyuki, et al.
Publicado: (2021)

Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
por: Tanaka, Yuko, et al.
Publicado: (2022)

Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
por: Aono, Yuya, et al.
Publicado: (2020)

Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients
por: Kusagaya, Hideki, et al.
Publicado: (2012)

Pulse oximetric saturation to fraction of inspired oxygen (SpO(2)/FIO(2)) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease
por: Koyauchi, Takafumi, et al.
Publicado: (2020)

Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study
por: Koyauchi, Takafumi, et al.
Publicado: (2022)

Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease
por: Yoshimura, Katsuhiro, et al.
Publicado: (2018)

Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease
por: Enomoto, Yasunori, et al.
Publicado: (2017)

Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis
por: Suzuki, Yuzo, et al.
Publicado: (2021)

Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study
por: Suzuki, Yuzo, et al.
Publicado: (2021)

Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF)
por: Enomoto, Noriyuki, et al.
Publicado: (2014)

Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study
por: Suzuki, Takahito, et al.
Publicado: (2021)

Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
por: Hozumi, Hironao, et al.
Publicado: (2022)

Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia
por: Kazuo, Tsuchiya, et al.
Publicado: (2019)

Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia
por: Tsuchiya, Kazuo, et al.
Publicado: (2020)

Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias
por: Hozumi, Hironao, et al.
Publicado: (2018)

Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis
por: Enomoto, Noriyuki, et al.
Publicado: (2019)

An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases
por: Tsuchiya, Kazuo, et al.
Publicado: (2018)

Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray
por: Karayama, Masato, et al.
Publicado: (2021)

Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease
por: Koda, Keigo, et al.
Publicado: (2021)

Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy
por: Karayama, Masato, et al.
Publicado: (2021)

Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice
por: Akahori, Daisuke, et al.
Publicado: (2022)

Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis
por: Enomoto, Noriyuki, et al.
Publicado: (2018)

Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases
por: Enomoto, Noriyuki, et al.
Publicado: (2022)

A predictive model for acute exacerbation of idiopathic interstitial pneumonias
por: Karayama, Masato, et al.
Publicado: (2023)

Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival
por: Aoshima, Yoichiro, et al.
Publicado: (2021)

Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians
por: Koyauchi, Takafumi, et al.
Publicado: (2022)

Physiological and morphological differences of airways between COPD and asthma–COPD overlap
por: Karayama, Masato, et al.
Publicado: (2019)

Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease
por: Karayama, Masato, et al.
Publicado: (2019)

Respiratory impedance is correlated with morphological changes in the lungs on three-dimensional CT in patients with COPD
por: Karayama, Masato, et al.
Publicado: (2017)

Relationship between fraction of exhaled nitric oxide and airway morphology assessed by three-dimensional CT analysis in asthma
por: Nishimoto, Koji, et al.
Publicado: (2017)

Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial
por: Furuhashi, Kazuki, et al.
Publicado: (2019)

Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy: The Authors' Reply
por: Karayama, Masato, et al.
Publicado: (2019)

Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer
por: Aoshima, Yoichiro, et al.
Publicado: (2019)

Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas
por: Akahori, Daisuke, et al.
Publicado: (2021)

Histological evolution of pleuroparenchymal fibroelastosis
por: Hirota, Takako, et al.
Publicado: (2015)

Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD
por: Suzuki, Yuzo, et al.
Publicado: (2019)

Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non–Small Cell Lung Cancer After Nivolumab Therapy
por: Karayama, Masato, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jtgac1d1gv80fpqq20siojmunn